| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | Director | See Remarks
3 companies
Brennan Aoife serves as a See Remarks at SYBX and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 0 buys and 6 sells. Those positions are worth an estimated $1.8M at current prices.
Historically, Brennan Aoife's trades have earned a middling insider score of 58/100 across 4 rated trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +37.6%.
The biggest single holding is CLYM (~$1.2M) as President and CEO. The recent filings there lean toward selling, a net 51,520 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | CLYM Climb Bio Inc | President and CEO | Sale+OE10b5-1 | 30,902 | $13.17 | $406,979.34 | -26.0% | -12.1% | - | |
| Jun 30, 2025 | CLYM Climb Bio, Inc. | President and CEO | Sale+OE10b5-1 | 20,618 | $1.22 | $25,153.96 | -30.0% | +60.5% | +951.6% | |
| Jun 9, 2023 | KYNB Fibrogen Inc | Director | Sell10b5-1 | 4,733 | $17.19 | $81,366.84 | -14.5% | -94.2% | -93.5% | |
| Apr 3, 2023 | SYBX Synlogic, Inc. | See Remarks | Sell10b5-1 | 19,042 | $0.58 | $10,964.38 | -6.9% | -29.4% | -79.8% | |
| Apr 4, 2022 | SYBX Synlogic, Inc. | See Remarks | Sell | 8,894 | $2.45 | $21,753.83 | -3.1% | -57.5% | -77.0% |